SARS-CoV-2 Vaccine Induced Antibody Profiles: Development and Utilization of Multiplex Assay

Get in Touch

Our Locations

Bob Bailer, Ph.D.

SARS-CoV-2 Vaccine Induced Antibody Profiles: Development and Utilization of Multiplex Assay

World Vaccine Congress 2020 Virtual Presentation

This presentation covers:

An overview of SARS-CoV-2 vaccine development
Target antigens for vaccine development
SARS-CoV-2 assays at Q²Solutions

To learn more, download presentation slides or watch recorded presentation.

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...